Press Release Description

Rigorous R&D Activities by Biopharma Companies to Drive the Protein Characterization & Identification Market

A recent research report published by MarkNtel Advisors cites that the Global Protein Characterization and Identification Market is set to register around 13.4% CAGR during 2022-27. The mounting influx of patients suffering from numerous chronic diseases, i.e., instigating healthcare professionals to increase their R&D activities in protein characterization & identification and bring novel therapeutics in order to cater to the high unmet patient needs worldwide, is driving the global market.

Besides, governments of different countries are also playing a prominent role in the market expansion through massive investments in the industry and favorable policies for clinical trials to strengthen the entire healthcare industry. These aspects are principally for bringing innovations in the protein characterization & identification technology to attain fruitful outcomes. 

Moreover, as more and more patients are becoming aware of such technologies, they are increasingly accepting personalized medicine. It, in turn, is also propelling the demand for these technologies for drug discovery & development activities and fueling the overall market growth, further states the research report, "Global Protein Characterization and Identification Market Analysis, 2022."

High Accuracy Rate Achieved Through Mass Spectrometry Instruments to Boost the Market

Mass spectrometry instruments use biological samples for the characterization & identification of proteins. More and more healthcare professionals are garnering command of these instruments owing to their capabilities to produce & separate ions upon mass to charge (m/z) ratio. According to different studies worldwide, these devices are used extensively for determining the quantification of proteins accurately. Hence, the rapidly surging demand for these instruments is augmenting the growth of the Global Protein Characterization & Identification Market.

With Rising Patient Pool of Chronic Illnesses, Asia-Pacific to Dominate the Market through 2027

Asia-Pacific is witnessing an increasing influx of people suffering from chronic diseases across its numerous countries. As a result, there's a growing need across the region for novel therapeutics to address these concerns. i.e., instigating several researchers to study protein dynamics and develop effective treatments.

Besides, massive investments by the governments in support of these technologies, coupled with the active participation of the leading regional players in numerous research & development initiatives, are further projecting a notable expansion of the Asia-Pacific Protein Characterization and Identification Market over the forecast years.

Competitive Landscape

The major companies in the Global Protein Characterization and Identification Market include Advion, Inc., Agilent Technologies, Analytik Jena, Creative Proteomics, Cleaver Scientific, Danaher Corporation, HORIBA Ltd., JEOL Ltd., MassTech Inc., Merck KGaA, MS Bioworks, Promega Corporation, QIAGEN N.V., Rigaku Corporation, Sartorius AG, SERVA Electrophoresis GmbH, Thermo Fisher Scientific, VProteomics, and Waters Corporation.

Key Questions Answered in the Research Report

  1. What are the current & future trends in the Global Protein Characterization and Identification Market?
  2. How has the industry been evolving in terms of geography & product adoption?
  3. How has the competition been shaping across various countries, followed by their comparative factorial indexing?
  4. What are the key growth drivers & challenges for the Global Protein Characterization and Identification Market?
  5. What are the customer orientation, purchase behavior, & expectations from the prominent players in the Global Protein Characterization and Identification Market?

Market Segmentation:

  1. By Products (Consumables (Chromatography, Electrophoresis, Immunoassay, Mass Spectrometry), Instruments (Chromatography, Electrophoresis, Label-free Detection, Mass Spectrometry, Spectroscopy)
  2. By Services (Clinical Diagnosis, Drug Discovery & Development)
  3. By End-User (Academic Research Institutes, Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies)
  4. By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific)
  5. By Countries (The US, Canada, Mexico, Brazil, Germany, The UK, France, Italy, Spain, South Africa, GCC, China, India, Japan, Australia)